Democratic Super PAC Uses Familiar Political Play To Hit Trump On Medicare
This is a tactic that we’ve seen before.
Search
Filter
Clear All1,341 - 1,360 of 1,672 Results
-
-
In Trump’s First Year, Anti-Abortion Forces Make Strides Despite Setbacks
As a candidate, the president promised a ban on abortions that take place after 20 weeks and federal funding to Planned Parenthood, but Congress has not obliged. Still, other anti-abortion policy goals have been realized.
By Julie Rovner -
It’s Not Just Insulin: Lawmakers Focus on Price of One Drug, While Others Rise Too
While insulin is the poster child for outrageous prescription costs, patients are paying ever more to treat depression, asthma, HIV, cholesterol and more. And the pandemic has overtaken efforts to force the issue in Congress.
-
These Secret Safety Panels Will Pick the COVID Vaccine Winners
Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.
-
Fallout From ‘Nuclear Button’ Tweets: Sales Of Anti-Radiation Drug Skyrocket
Orders for potassium iodide reportedly jumped after a Jan. 2 war of words between Trump and North Korea’s Kim Jong-un.
-
Despite Compressed Sign-Up Period, ACA Enrollment Nearly Matches Last Year’s
HHS announces that 8.8 million people signed up for coverage through the federal insurance marketplace.
By Julie Rovner -
KHN’s ‘What the Health?’: The Long Road to Unwinding Trump Health Policies
President Joe Biden signed a pair of health-related executive orders this week that would, among other things, reopen enrollment under the Affordable Care Act and start to reverse former President Donald Trump’s anti-abortion policies. Meanwhile, Congress remains bogged down with taking up the next round of covid-19 relief. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
Opioid Crisis Hits Home: Uncle’s Overdose Spurs Medicaid Official To Change Course
Andrey Ostrovsky, who until last month was chief medical officer for Medicaid, quit his job so he could more directly fight the stigma of drug addiction.
-
Trump Administration Relaxes Financial Penalties Against Nursing Homes
Medicare is discouraging regional offices from levying fines for “one-time mistakes” or from using daily fines that seek to put pressure on nursing homes to make changes.
By Jordan Rau -
Biden Falsely Blames Trump Administration For Rejecting WHO Coronavirus Test Kits (That Were Never Offered)
Biden’s statement leaves out context about how countries decided on which test they’d use to identify the presence of the coronavirus.
-
Telemedicine For Addiction Treatment? Picture Remains Fuzzy
One Indiana addiction specialist doesn't shy away from telemedicine, but he still requires in-person visits to begin and maintain his patients' Suboxone prescriptions.
-
Cloud Of Uncertainty Over Legalized Pot As Feds End Obama-Era Accommodation
Officials in marijuana-friendly states reacted strongly to new guidance from U.S. Attorney General Jeff Sessions giving federal prosecutors leeway to crack down on cannabis.
By Anna Gorman and Phil Galewitz -
White House Left States On Their Own To Buy Ventilators. Inside Their Mad Scramble.
Although laws prohibit price gouging on precious resources in times of emergency, states have been forced to compete for a share of the nation’s stockpile of ventilators — used to treat the sickest COVID patients — or pay top dollar on sideline deals. With quality and quantity control lacking, what happens when the pandemic’s second wave hits?
-
About A Third Of Americans Unaware Of Obamacare Open Enrollment
Nonetheless, federal officials report sign-ups are robust so far this year.
-
Drug Industry Spent Millions To Squelch Talk About High Drug Prices
Last year, the pharma industry’ biggest trade group raised millions to change the conversation about drug pricing.
By Jay Hancock -
Canada’s Single-Payer Health System: What Is True? What Is False?
It’s a regular part of the politically charged debate over health care. But the lines sometimes blur between rhetoric and how Canada’s system actually works.
-
Repeal & Replace Watch
Facebook Live: Things To Know About Trump’s Directive On Health Insurance
In this Facebook Live, KHN’s Julie Appleby answers questions about President Donald Trump’s executive order regarding insurance.
-
Repeal & Replace Watch
Facebook Live: Trump Ends Payments For Cost-Sharing Reductions. What’s Next?
In this Facebook Live chat, KHN's Jay Hancock answers questions about President Donald Trump’s announcement that he will end federal payments for the Affordable Care Act’s cost-sharing reductions.
-
Sen. Collins’ Strategy To Stabilize Insurance Market Raises Doubts Among Analysts
Even if the Republican from Maine can get her party to go along, her suggestions to bolster the individual insurance market may be too little, too late.
By Julie Rovner -
FDA Raids Florida Stores That Consumers Use To Buy Drugs From Canada
The federal agents warned store owners that importing drugs from foreign countries is illegal and that those helping “administer” such medicines could face penalties.